Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedhelm Leverkus

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 1, 2014
[Methodology for analysing quality-of-life data in the benefit assessment of pharmaceuticals]Friedhelm Leverkus
Biometrical Journal. Biometrische Zeitschrift|September 3, 2015
Implementation of AMNOG: An industry perspectiveFriedhelm Leverkus, Christy Chuang-Stein
Pharmaceutical Statistics|June 14, 2016
Safety data from randomized controlled trials: applying models for recurrent eventsJohannes Hengelbrock, Johanna Gillhaus, Sebastian Kloss, et al.
BMC Medical Research Methodology|June 19, 2019
Does big data require a methodological change in medical research?Amke Caliebe, Friedhelm Leverkus, Gerd Antes, et al.
Methods of Information in Medicine|April 1, 2017
Evaluation of Adjusted and Unadjusted Indirect Comparison Methods in Benefit Assessment. A Simulation Study for Time-to-event EndpointsSarah Kühnast, Julia Schiffner-Rohe, Jörg Rahnenführer, et al.
BMC Medical Research Methodology|July 13, 2023
Safety analysis of new medications in clinical trials: a simulation study to assess the differences between cause-specific and subdistribution frameworks in the presence of competing eventsAstrid Genet, Kathrin Bogner, Ralf Goertz, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 28, 2018
[Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system]Christoph Ohlmeier, Friedhelm Leverkus, Sebastian Kloss, et al.
Diabetes Care|June 19, 2007
Development and validation of a new measure to evaluate psychological resistance to insulin treatmentFrank Petrak, Elmar Stridde, Friedhelm Leverkus, et al.
Frontiers in Public Health|March 7, 2022
Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquineStefanie Wüstner, Sara Hogger, Daniela Gartner-Freyer, et al.
BMC Research Notes|January 16, 2019
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study resultsChristoph Gerlinger, Luke Bamber, Friedhelm Leverkus, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 1, 2014
[Methodology for analysing quality-of-life data in the benefit assessment of pharmaceuticals]Friedhelm Leverkus
Biometrical Journal. Biometrische Zeitschrift|September 3, 2015
Implementation of AMNOG: An industry perspectiveFriedhelm Leverkus, Christy Chuang-Stein
Pharmaceutical Statistics|June 14, 2016
Safety data from randomized controlled trials: applying models for recurrent eventsJohannes Hengelbrock, Johanna Gillhaus, Sebastian Kloss, et al.
BMC Medical Research Methodology|June 19, 2019
Does big data require a methodological change in medical research?Amke Caliebe, Friedhelm Leverkus, Gerd Antes, et al.
Methods of Information in Medicine|April 1, 2017
Evaluation of Adjusted and Unadjusted Indirect Comparison Methods in Benefit Assessment. A Simulation Study for Time-to-event EndpointsSarah Kühnast, Julia Schiffner-Rohe, Jörg Rahnenführer, et al.
BMC Medical Research Methodology|July 13, 2023
Safety analysis of new medications in clinical trials: a simulation study to assess the differences between cause-specific and subdistribution frameworks in the presence of competing eventsAstrid Genet, Kathrin Bogner, Ralf Goertz, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 28, 2018
[Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system]Christoph Ohlmeier, Friedhelm Leverkus, Sebastian Kloss, et al.
Diabetes Care|June 19, 2007
Development and validation of a new measure to evaluate psychological resistance to insulin treatmentFrank Petrak, Elmar Stridde, Friedhelm Leverkus, et al.
Frontiers in Public Health|March 7, 2022
Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquineStefanie Wüstner, Sara Hogger, Daniela Gartner-Freyer, et al.
BMC Research Notes|January 16, 2019
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study resultsChristoph Gerlinger, Luke Bamber, Friedhelm Leverkus, et al.
Pageof 2